Capecitabine (capecitabine): Reviews and patient testimonials

Capecitabine Accord 150,300,500 mg film coated tablets

Capecitabine Accord is indicated for the treatment of:

-for the adjuvant treatment of patients following surgery of stage III (Dukes' stage C) colon cancer.

- metastatic colorectal cancer.

- first-line treatment of advanced gastric cancer in combination with a platinum based regimen.

in combination with docetaxel for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline.

as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.

Capecitabine Actavis 150mg Film-coated Tablets

Capecitabine is indicated for the treatment of:

- adjuvant treatment of patients following surgery of stage III (Dukes' stage C) colon cancer.

- metastatic colorectal cancer.

- first-line treatment of advanced gastric cancer in combination with a platinum-based regimen.

- in combination with docetaxel for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline.

- as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.

Capecitabine Actavis 500mg Film-coated Tablets

Capecitabine is indicated for the treatment of:

- for the adjuvant treatment of patients following surgery of stage III (Dukes' stage C) colon cancer.

- metastatic colorectal cancer.

- first-line treatment of advanced gastric cancer in combination with a platinumbased regimen.

- in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline.

- as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.

Capecitabine Dr. Reddys 150 mg Film-Coated Tablets

Capecitabine is indicated for the treatment of:

- for the adjuvant treatment of patients following surgery of stage III (Dukes' stage C) colon cancer.

- metastatic colorectal cancer.

- first-line treatment of advanced gastric cancer in combination with a platinum-based regimen.

- in combination with docetaxel for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline.

- as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline-containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.

Capecitabine Dr. Reddys 500 mg Film-Coated Tablets

Capecitabine is indicated for the treatment of:

- for the adjuvant treatment of patients following surgery of stage III (Dukes' stage C) colon cancer.

- metastatic colorectal cancer.

- first-line treatment of advanced gastric cancer in combination with a platinum-based regimen.

- in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline.

- as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline- containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.

Capecitabine medac film-coated tablets

Capecitabine medac is indicated:

• for the adjuvant treatment of patients following surgery of stage III (Dukes' stage C) colon cancer.

• for the treatment of metastatic colorectal cancer.

• for first-line treatment of advanced gastric cancer in combination with a platinum based regimen.

• in combination with docetaxel for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline.

• as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.

Capecitabine Mylan 150 mg film-coated tablets

Capecitabine Mylan is indicated for the adjuvant treatment of patients following surgery of stage III (Dukes' stage C) colon cancer.

Capecitabine Mylan is indicated for the treatment of metastatic colorectal cancer.

Capecitabine Mylan is indicated for first-line treatment of advanced gastric cancer in combination with a platinum-based regimen.

Capecitabine Mylan in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline. Capecitabine Mylan is also indicated as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline-containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.

Capecitabine Mylan 500 mg film-coated tablets

Capecitabine Mylan is indicated for the adjuvant treatment of patients following surgery of stage III (Dukes' stage C) colon cancer.

Capecitabine Mylan is indicated for the treatment of metastatic colorectal cancer.

Capecitabine Mylan is indicated for first-line treatment of advanced gastric cancer in combination with a platinum-based regimen.

Capecitabine Mylan in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline. Capecitabine Mylan is also indicated as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline-containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.